Pregnant and puerperal women's knowledge and awareness of venous thromboembolism: a medical of things survey technique

Pregnant women are at a higher risk of venous thromboembolism (VTE) during pregnancy and postpartum. Coronavirus disease 2019 (COVID-19) infection increases the risk of VTE. This study aimed to assess pregnant and puerperal women’s knowledge and awareness of VTE. The study included 403 females at the maternity hospital in the Al-Ahsa region, Saudi Arabia. All participants were chosen by convenience sampling technique and interviewed about their bio-demographic, clinical, and gynecological data, personal and/or family history of VTE, history of thromboprophylaxis, and knowledge about deep vein thrombosis (DVT) and pulmonary embolism (PE). The results of the study revealed that 284 (70.5%) of the participants had poor knowledge about DVT, and only 119 (29.5%) had a good level of knowledge, with a mean score of 8.7 out of 20. Although VTE prevalence has increased due to COVID-19 and its complications, the study results showed a lack of knowledge and poor awareness of VTE among 70.5% of the study participants. The education of women regarding VTE should be improved, especially among pregnant females. More patient education and public education campaigns are needed to increase public awareness of VTE, especially during the COVID-19 pandemic.

Venous thromboembolism; COVID-19; Postpartum; Obstetric hemorrhage

[1] Phillips OP. Venous thromboembolism in the pregnant woman. The Journal of Reproductive Medicine. 2003; 48: 921–929.

[2] Thorneycroft IH, Goldzieher JW. Venous thromboembolism. A review. The Journal of Reproductive Medicine. 2003; 48: 911–920.

[3] Elmaghraby DA, Al-Bassri ZK, AlTuraiki ZA, Alsaleh JA, Alzuwayyid LS, Albanyan NA, et al. Assessment of Saudi women’s adherence and experience with venous thromboembolism prophylaxis after cesarean section delivery using telemedicine technology. Applied Bionics and Biomechanics. 2022; 2022: 1–8.

[4] James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstetrics & Gynecology. 2005; 106: 509–516.

[5] James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboem-bolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality. American Journal of Obstetrics and Gynecology. 2006; 194: 1311–1315.

[6] Tan EK, Tan EL. Alterations in physiology and anatomy during pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology. 2013; 27: 791–802.

[7] Simcox LE, Ormesher L, Tower C, Greer IA. Pulmonary thrombo-embolism in pregnancy: diagnosis and management. Breathe. 2015; 11: 282–289.

[8] Royal College of Obstetrics and Gynaecology. Reducing the risk of venous thromboembolism during pregnancy and the puerperium pregnancy and the puerperium. Green Top Guideline. 2015; 37a.

[9] O’Shaughnessy F, Donnelly JC, Bennett K, Damkier P, Áinle FN, Cleary BJ. Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population. Journal of Thrombosis and Haemostasis. 2019; 17: 1875–1885.

[10] Alsheef MA, Alabbad AM, Albassam RA, Alarfaj RM, Zaidi ARZ, Al-Arfaj O, et al. Pregnancy and venous thromboembolism: risk factors, trends, management, and mortality. BioMed Research International. 2020; 2020: 1–6.

[11] Andrew L, Ní Áinle F, Blondon M, Rodger MA, Skeith L. Preventing postpartum venous thromboembolism: a call to action to reduce undue maternal morbidity and mortality. Thrombosis Research. 2020; 193: 190–197.

[12] Creanga AA, Johnson TF, Graitcer SB, Hartman LK, Al-Samarrai T, Schwarz AG, et al. Severity of 2009 pandemic influenza a (H1N1) virus infection in pregnant women. Obstetrics & Gynecology. 2010; 115: 717–726.

[13] Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American College of Cardiology. 2020; 75: 2950–2973.

[14] Servante J, Swallow G, Thornton JG, Myers B, Munireddy S, Malinowski AK, et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy and Childbirth. 2021; 21: 108.

[15] D’Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstetricia Et Gynecologica Scandinavica. 2020; 99: 1110–1120.

[16] Benhamou D, Keita H, Ducloy-Bouthors AS; Obstetric Anaesthesia and Critical Care Club Working Group. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesthesia Critical Care & Pain Medicine. 2020; 39: 351–353.

[17] Kadir RA, Kobayashi T, Iba T, Erez O, Thachil J, Kazi S, et al. COVID-19 coagulopathy in pregnancy: critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for women’s health. Journal of Thrombosis and Haemostasis. 2020; 18: 3086–3098.

[18] Nana M, Nelson-Piercy C. COVID-19 in pregnancy. Clinical Medicine. 2021; 21: e446–e450.

[19] Alsayegh F, Al-Jassar W, Wani S, Tahlak M, Albahar A, Al Kharusi L, et al. Venous thromboembolism risk and adequacy of prophylaxis in high risk pregnancy in the Arabian gulf. Current Vascular Pharmacology. 2016; 14: 368–373.

[20] Deneux-Tharaux C, Carmona E, Bouvier-Colle M, Bréart G. Postpartum maternal mortality and cesarean delivery. Obstetrics & Gynecology. 2006; 108: 541–548.

[21] Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012; 141: e691S–e736S.

[22] West MJ, Irvine LM, Jauniaux E. Caesarean section: from antiquity to the twenty-first century. In Jauniaux E, Grobman WA (ed). Textbook of caesarean section (pp 9–24). 1st ed. Oxford University Press: Oxford, UK. 2016.

[23] VanOtterloo LR, Seacrist MJ, Morton CH, Main EK. Quality improvement opportunities identified through case review of pregnancy-related deaths from venous thromboembolism. Journal of Obstetric, Gynecologic & Neonatal Nursing. 2019; 48: 300–310.

[24] Fogerty AE. Management of venous thromboembolism in pregnancy. Current Treatment Options in Cardiovascular Medicine. 2018; 20: 69.

[25] Wendelboe AM, McCumber M, Hylek EM, Buller H, Weitz JI, Raskob G, et al. Global public awareness of venous thromboembolism. Journal of Thrombosis and Haemostasis. 2015; 13: 1365–1371.

[26] Alzoubi KH, Khassawneh BY, Obeidat B, Asfoor SS, Al-azzam SI. Awareness of patients who undergo cesarean section about venous thromboembolism prophylaxis. Journal of Vascular Nursing. 2013; 31: 15–20.

[27] Cushman M, Barnes GD, Creager MA, Diaz JA, Henke PK, Machlus KR, et al. Venous thromboembolism research priorities: a scientific statement from the American heart association and the international society on thrombosis and haemostasis. Research and Practice in Thrombosis and Haemostasis. 2020; 4: 714–721.

[28] Elmaghraby DA, Alshalla AA, Alyahyan A, Altaweel M, Al ben Hamad AM, Alhunfoosh KM, et al. Public Knowledge, Practice, and Attitude Regarding Cancer Screening: A Community-Based Study in Saudi Arabia. International Journal of Environmental Research and Public Health. 2023; 20: 1114.

[29] Elmaghraby DA, Al-Bassri ZK, AlTuraiki ZA, Alsaleh JA, Alzuwayyid LS, Albanyan NA, et al. Assessment of Saudi Women’s Adherence and Experience with Venous Thromboembolism Prophylaxis after Cesarean Section Delivery Using Telemedicine Technology. Applied Bionics and Biomechanics. 2022; 2022.

[30] Mellon M, Schiller A, Nelson AL, Stohl HE. Awareness of pregnancy-associated health risks among pregnant women and male partners surveyed in a prenatal clinic. Journal of Women’S Health. 2020; 29: 376–382.

[31] Almodaimegh H, Alfehaid L, Alsuhebany N, Bustami R, Alharbi S, Alkatheri A, et al. Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study. Thrombosis Journal. 2017; 15: 19.

[32] Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. British Journal of Haematology. 2012; 156: 366–373.

[33] American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin No. 196: thromboembolism in pregnancy. Obstetrics and Gynecology. 2018; 132: e1–e17.

[34] Dresang LT, Fontaine P, Lawrence L, King VJ. Venous thromboembolism during pregnancy. American Family Physician. 2008; 77: 1709–1716.

[35] Mohammad WT, Mabrouk SH, Mostafa RMAE, Younis MB, Al Sayeh AM, Ebrahim MAA, et al. Artificial intelligence technique of synthesis and characterizations for measurement of optical particles in medical devices. Applied Bionics and Biomechanics. 2022; 2022: 1–5.

[36] Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M, Smith NL. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest. 2016; 150: 572–596.

[37] Henke PK, Kahn SR, Pannucci CJ, Secemksy EA, Evans NS, Khorana AA, et al. Call to action to prevent venous thromboembolism in hospitalized patients: a policy statement from the American heart association. Circulation. 2020; 141: e914–e931.

[38] Ismail L, Normahani P, Standfield NJ, Jaffer U. A systematic review and meta-analysis of the risk for development of varicose veins in women with a history of pregnancy. Journal of Vascular Surgery. 2016; 4: 518–524.e1.

[39] Hahn RA, Truman BI. Education improves public health and promotes health equity. International Journal of Health Services. 2015; 45: 657–678.

[40] Pereira A, Cruz‐Melguizo S, Adrien M, Fuentes L, Marin E, Perez-Medina T. Clinical course of coronavirus disease-2019 in pregnancy. Acta Obstetricia Et Gynecologica Scandinavica. 2020; 99: 839–847.

[41] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395: 1054–1062.

[42] Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboem-bolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020; 18: 1421–1424.

[43] Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Review of Hematology. 2020; 13: 1265–1275.

[44] Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstetricia Et Gynecologica Scandinavica. 2020; 99: 823–829.

[45] D’Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstetricia Et Gynecologica Scandinavica. 2020; 99: 1110–1120.

[46] Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection. The INTERCOVID multinational cohort study. JAMA Pediatrics. 2021; 175: 817–826.

[47] Bahrami R, Schwartz DA, Karimi-Zarchi M, Javaheri A, Dastgheib SA, Ferdosian F, et al. Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19. Turkish Journal of Obstetrics and Gynecology. 2021; 18: 236–244.